Communicating for the Safe Use of Medicines : Progress and Directions for the 2020s Promoted by the Special Interest Group of the International Society of Pharmacovigilance
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:46 |
|---|---|
| Enthalten in: |
Drug safety - 46(2023), 6 vom: 17. Juni, Seite 517-532 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bahri, Priya [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 29.05.2023 Date Revised 30.05.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s40264-023-01285-5 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM357222229 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM357222229 | ||
| 003 | DE-627 | ||
| 005 | 20231226072124.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s40264-023-01285-5 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1190.xml |
| 035 | |a (DE-627)NLM357222229 | ||
| 035 | |a (NLM)37219785 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bahri, Priya |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Communicating for the Safe Use of Medicines |b Progress and Directions for the 2020s Promoted by the Special Interest Group of the International Society of Pharmacovigilance |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 29.05.2023 | ||
| 500 | |a Date Revised 30.05.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 700 | 1 | |a Bowring, Geoffrey |e verfasserin |4 aut | |
| 700 | 1 | |a Edwards, Brian D |e verfasserin |4 aut | |
| 700 | 1 | |a Anton, Christopher |e verfasserin |4 aut | |
| 700 | 1 | |a Aronson, Jeffrey K |e verfasserin |4 aut | |
| 700 | 1 | |a Caro-Rojas, Angela |e verfasserin |4 aut | |
| 700 | 1 | |a Hugman, Bruce P J |e verfasserin |4 aut | |
| 700 | 1 | |a Mol, Peter G |e verfasserin |4 aut | |
| 700 | 1 | |a Trifirò, Gianluca |e verfasserin |4 aut | |
| 700 | 1 | |a Ilic, Katarina |e verfasserin |4 aut | |
| 700 | 1 | |a Daghfous, Riadh |e verfasserin |4 aut | |
| 700 | 1 | |a Fermont, Irene |e verfasserin |4 aut | |
| 700 | 1 | |a Furlan, Giovanni |e verfasserin |4 aut | |
| 700 | 1 | |a Gaissmaier, Wolfgang |e verfasserin |4 aut | |
| 700 | 1 | |a Geer, Mohammad Ishaq |e verfasserin |4 aut | |
| 700 | 1 | |a Hartigan-Go, Kenneth Y |e verfasserin |4 aut | |
| 700 | 1 | |a Houÿez, François |e verfasserin |4 aut | |
| 700 | 1 | |a Neth, Hansjörg |e verfasserin |4 aut | |
| 700 | 1 | |a Norgela, Gediminas |e verfasserin |4 aut | |
| 700 | 1 | |a Oppamayun, Yaowares |e verfasserin |4 aut | |
| 700 | 1 | |a Raynor, D K Theo |e verfasserin |4 aut | |
| 700 | 1 | |a Bouhlel, Mehdi |e verfasserin |4 aut | |
| 700 | 1 | |a Santoro, Federica |e verfasserin |4 aut | |
| 700 | 1 | |a Sultana, Janet |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Drug safety |d 1993 |g 46(2023), 6 vom: 17. Juni, Seite 517-532 |w (DE-627)NLM013282689 |x 1179-1942 |7 nnns |
| 773 | 1 | 8 | |g volume:46 |g year:2023 |g number:6 |g day:17 |g month:06 |g pages:517-532 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s40264-023-01285-5 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 46 |j 2023 |e 6 |b 17 |c 06 |h 517-532 | ||